In the wake of the recent bank failures, bank regulators could likely adjust standards regarding securities held by banks.

The failures of various banks shouldn’t have a significant impact on investors of MBS and ABS, according to rating services.

The Fed won’t alter its plans for runoff in its MBS holdings amid recent bank failures; fate of Select Portfolio Servicing remains unclear.

CRT transactions from Western Alliance Bank and Pacific Western Bank face scrutiny amid bank failures; impairments on unsecured consumer loans in ABS decline; Credit Suisse and what’s to come.

The RMBS rating business nearly ground to a halt in the fourth quarter, but ECM was the place to be in 2022. ABS fared a little better, with business-finance and consumer deals showing relative strength. (Includes two data charts.)

After undertaking drastic leadership changes in December, Chimera is now looking to expand its investments beyond reperforming loans.

FDIC monitoring commercial MBS performance; MISMO to update ASF data standards; ACC subprime auto ABS servicing update.

After playing defense in 2022, investors appear to be willing to deploy capital even as the MBS and ABS markets face numerous headwinds. Attendance at this week’s SFVegas conference hit a record level.

Prime jumbos are unlikely to account for the majority of non-agency MBS issued this year, a first for the products since the time before the financial crisis. Non-QM MBS issuance is holding up better and second-lien securitizations are building some momentum.

Finally, prices are starting to seem (somewhat) reasonable for non-agency whole loans of the non-QM variety. But this applies to recently originated product — where supply is lacking.